Rosa Fanci

4.5k total citations
62 papers, 1.7k citations indexed

About

Rosa Fanci is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Rosa Fanci has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 27 papers in Epidemiology and 25 papers in Oncology. Recurrent topics in Rosa Fanci's work include Antifungal resistance and susceptibility (19 papers), Neutropenia and Cancer Infections (17 papers) and Fungal Infections and Studies (17 papers). Rosa Fanci is often cited by papers focused on Antifungal resistance and susceptibility (19 papers), Neutropenia and Cancer Infections (17 papers) and Fungal Infections and Studies (17 papers). Rosa Fanci collaborates with scholars based in Italy, United States and South Africa. Rosa Fanci's co-authors include Livio Pagano, A. Azzi, Alberto Bosi, Lorella Melillo, Bruno Martino, K. Zakrzewska, Domenico D’Antonio, Corrado Girmenia, Gabriella Pini and Giorgina Specchia and has published in prestigious journals such as Blood, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Rosa Fanci

62 papers receiving 1.6k citations

Peers

Rosa Fanci
Ellis Tobin United States
Fred A. Gill United States
Richard L. Myerowitz United States
Eun Jeong Won South Korea
E.J. Kwak United States
Robert E. Gertz United States
Ilana Oren Israel
Rosa Fanci
Citations per year, relative to Rosa Fanci Rosa Fanci (= 1×) peers Pietro Martino

Countries citing papers authored by Rosa Fanci

Since Specialization
Citations

This map shows the geographic impact of Rosa Fanci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Fanci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Fanci more than expected).

Fields of papers citing papers by Rosa Fanci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Fanci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Fanci. The network helps show where Rosa Fanci may publish in the future.

Co-authorship network of co-authors of Rosa Fanci

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Fanci. A scholar is included among the top collaborators of Rosa Fanci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Fanci. Rosa Fanci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nadali, Gianpaolo, Anna Candoni, Chiara Cattaneo, et al.. (2020). Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study. Leukemia & lymphoma. 61(12). 3002–3005. 1 indexed citations
2.
Rigacci, Luigi, Umberto Restelli, Barbara Scappini, et al.. (2018). Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey. Journal of Blood Medicine. Volume 10. 21–27. 4 indexed citations
3.
Pepa, Roberta Della, Marco Picardi, Federica Sorà, et al.. (2016). Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry. Supportive Care in Cancer. 24(9). 3839–3845. 12 indexed citations
4.
Pagano, Livio, Luisa Verga, Alessandro Busca, et al.. (2014). Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey. Journal of Antimicrobial Chemotherapy. 69(11). 3142–3147. 16 indexed citations
5.
Nosari, A., Morena Caira, Rosa Fanci, et al.. (2012). Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections. Clinical Microbiology and Infection. 19(8). 757–762. 25 indexed citations
6.
Scappini, Barbara, Giacomo Gianfaldoni, F Caracciolo, et al.. (2012). Cytarabine and clofarabine after high‐dose cytarabine in relapsed or refractory AML patients. American Journal of Hematology. 87(12). 1047–1051. 21 indexed citations
7.
Tumbarello, Mario, Enrico Maria Trecarichi, Morena Caira, et al.. (2012). Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality. PLoS ONE. 7(12). e51612–e51612. 23 indexed citations
8.
Pagano, Livio, Michele Caira, A. Nosari, et al.. (2011). The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. Haematologica. 96(9). 1366–1370. 51 indexed citations
9.
Longoni, Biancamaria, Paola Quaranta, Sergio Tripodi, et al.. (2010). Mesenchymal Stem Cells Prevent Acute Rejection and Prolong Graft Function in Pancreatic Islet Transplantation. Diabetes Technology & Therapeutics. 12(6). 435–446. 58 indexed citations
10.
Corcioli, Fabiana, K. Zakrzewska, Rosa Fanci, et al.. (2010). Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virology Journal. 7(1). 272–272. 24 indexed citations
11.
Pini, Gabriella, Elisabetta Faggi, Rosa Donato, Cristiana Sacco, & Rosa Fanci. (2007). Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses. 51(2). 117–122. 35 indexed citations
12.
Fanci, Rosa, Patrizia Pecile, Enrico Casalone, et al.. (2006). Pseudomonas aeruginosaSepsis in Stem Cell Transplantation Patients. Infection Control and Hospital Epidemiology. 27(7). 767–770. 3 indexed citations
13.
Taliani, Gloria, Alessandro Tozzi, Rosa Fanci, Elisa Biliotti, & Alberto Bosi. (2006). Fatal Acute Hepatitis C Virus Infection in Patients with Hematological Malignancies. Journal of Chemotherapy. 18(6). 662–664. 2 indexed citations
15.
Fanci, Rosa, et al.. (2004). Incidence and Management of Proven and Probable Fungal Infections in Patients with Acute Leukemia: A Single Center Experience. Journal of Chemotherapy. 16(6). 557–560. 1 indexed citations
16.
Azzi, A., et al.. (2001). Human herpesvirus 8 DNA sequences are present in bone marrow from HIV‐negative patients with lymphoproliferative disorders and from healthy donors. British Journal of Haematology. 113(1). 188–190. 4 indexed citations
17.
Bosi, Alberto, Daniele Laszlò, Silvia Bacci, et al.. (1999). An Open Evaluation of Triple Antibiotic Therapy Including Vancomycin for Febrile Bone Marrow Transplant Recipients with Severe Neutropenia. Journal of Chemotherapy. 11(4). 287–292. 2 indexed citations
18.
Fanci, Rosa, et al.. (1997). Amphotericin B Treatment of Fungemia Due to Unusual Pathogens in Neutropenic Patients: Report of Two Cases. Journal of Chemotherapy. 9(6). 427–430. 13 indexed citations
19.
Viscoli, Claudio, Elio Castagnola, Maria Teresa Van Lint, et al.. (1996). Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. European Journal of Cancer. 32(5). 814–820. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026